LONDON – Immunocore Ltd. is expecting a $100 million payment before the end of the year, after it sealed a new agreement with Roche Holding AG subsidiary Genentech Inc. around IMC-C103C, a soluble T-cell receptor (TCR) product targeted at melanoma-associated antigen A4 (Mage-A4)-expressing solid tumors. Read More
SHANGHAI – Alphamab Oncology Co. Ltd. now has more than $100 million in its coffers to push its four top antibody candidates through the clinic in China, the U.S., Japan and Australia for the next two years. The series A financing came from venture investors Advantech Capital, PAG, China Venture Capital Fund, Orbimed, Heritage Provider Network and Janchor Partners. Read More
Biological drugs – monoclonal antibodies, peptides, recombinant proteins and the like – now account for more than 30 percent of all FDA approvals, according to a new study from the Tufts Center for the Study of Drug Development. Read More
LONDON – After months in limbo, the life sciences industry welcomed the long-awaited draft of the terms for U.K. withdrawal from the EU with relief. But the political chaos its publication has unleashed means the uncertainties of Brexit are grinding on. Read More
HONG KONG – The Indian government reportedly made moves in late October to prevent the rupee from falling further against the U.S. dollar. While the Indian currency is expected to benefit from the proposed plan, local pharmaceutical firms are likely to suffer from a stronger rupee. Read More
Gen1E Lifesciences Inc., of Palo Alto, Calif., said it entered an exclusive option agreement with the University of Maryland, Baltimore to license patent rights, titled "MUC1 Decoy Peptides for Treatment and Prevention of Bacterial Infections." Terms were not disclosed. Read More
Quralis Corp., of Cambridge, Mass., raised a seed round extension from new investors, Bioinnovation Capital and Viva Biotech Ltd., which were joined by existing biotech investors, including MP Healthcare Venture Management and Amgen Venture. To date, Quralis has raised $5.5 million. Read More
